Cargando…
Case report: VA-ECMO for fulminant myocarditis in an infant with acute COVID-19
Fulminant myocarditis in children was rare during the coronavirus disease 2019 pandemic, but it had the potential for high morbidity and mortality. We describe the clinical course of a previously healthy 9-month-old young male infant who rapidly deteriorated into cardiogenic shock due to coronavirus...
Autores principales: | Hsu, Hao-Ting, Kuo, Ni-Chun, Chen, Po-Yen, Jan, Sheng-Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333478/ https://www.ncbi.nlm.nih.gov/pubmed/37441568 http://dx.doi.org/10.3389/fped.2023.1180534 |
Ejemplares similares
-
Fulminant myocarditis in COVID-19 and favorable outcomes with VA-ECMO
por: Bhardwaj, Abhishek, et al.
Publicado: (2022) -
Delayed Diagnosis and Recovery of Fulminant Immune Checkpoint Inhibitor-Associated Myocarditis on VA-ECMO Support
por: Ramayya, Tarun, et al.
Publicado: (2022) -
Reverse TakoTsubo or Fulminant myocarditis ? Life saving VA ECMO in a COVID 19 patient
por: Hamdan, Righab, et al.
Publicado: (2022) -
Factors Associated With In-hospital Mortality of Children With Acute Fulminant Myocarditis on Extracorporeal Membrane Oxygenation
por: Lee, En-Pei, et al.
Publicado: (2020) -
Long Non-coding RNA Expression Profile and Functional Analysis in Children With Acute Fulminant Myocarditis
por: Liu, Qingqing, et al.
Publicado: (2019)